Physician profile
Stacy D Younger
NPI 1043212210
$22,235.79
in general payments reported to CMS, 2019-2025
70 companies · $3,717 in 2025
The $3,717 reported for 2025 was more than what 82% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,849 · 2020: $1,459 · 2021: $2,999 · 2022: $3,612 · 2023: $4,002 · 2024: $3,598 · 2025: $3,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $63.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,254.64 |
| Education | $63.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,074.25 | 2019-2025 | Ubrelvy, Qulipta, Duopa |
| Biogen, INC. | $1,613.06 | 2019-2025 | Tysabri, Vumerity, Avonex |
| Novartis Pharmaceuticals Corporation | $1,376.52 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,279.45 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Ucb, INC. | $1,122.74 | 2019-2025 | Briviact, Rystiggo, Fintepla |
| Emd Serono, INC. | $1,040.13 | 2019-2025 | Mavenclad |
| Genentech USA, INC. | $1,007.61 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Jazz Pharmaceuticals INC. | $874.18 | 2019-2025 | |
| Genzyme Corporation | $864.54 | 2019-2025 | |
| Lilly USA, LLC | $812.74 | 2019-2025 | Emgality, Amyvid, Kisunla |
| Celgene Corporation | $735.81 | 2021-2025 | Zeposia |
| Alexion Pharmaceuticals, INC. | $689.46 | 2019-2025 | Ultomiris |
| Amgen INC. | $682.94 | 2019-2024 | Aimovig, Uplizna |
| Pfizer INC. | $676.91 | 2023-2025 | |
| Argenx US, INC. | $446.51 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Younger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.